{"id":182484,"date":"2026-08-04T09:44:15","date_gmt":"2026-08-04T04:14:15","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=182484"},"modified":"2026-08-04T09:44:15","modified_gmt":"2026-08-04T04:14:15","slug":"dr-lal-pathlabs-ltd-share-price-52-week-high-2026-08-04","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/dr-lal-pathlabs-ltd-share-price-52-week-high-2026-08-04\/","title":{"rendered":"Dr. Lal Pathlabs Ltd. (LALPATHLAB) Share Price Hits 52-Week High"},"content":{"rendered":"<style id=\"univest-disable-toc\">#ez-toc-container,.ez-toc-container,.lwptoc,.toc_container,.wp-block-rank-math-toc-block{display:none!important}<\/style>\n<p style=\"margin-top:0!important;margin-bottom:0!important;;margin-top:0!important;margin-bottom:0!important;\"><a href=\"https:\/\/univest.in\/stocks\/lalpathlab\/dr-lal-pathlabs-ltd-share-price-today\">Dr. Lal Pathlabs Ltd.<\/a> Share Price reached a 52-week high of Rs 1,950.45, up 1.65% today, with a market cap of Rs 31,976.9 crore.<\/p>\n<p style=\"margin-top:0!important;;margin-top:0!important;\">Dr. Lal Pathlabs Ltd. Share Price has reached a new 52-week high of Rs 1,950.45, marking a significant milestone for the company. The stock closed at Rs 1,926.4, reflecting a 1.65% increase from the previous close of Rs 1,895.1. With a market capitalisation of Rs 31,976.9 crore, Dr. Lal Pathlabs Ltd. continues to capture investor attention in the healthcare sector. This achievement underscores the company&#8217;s strong market position and investor confidence, although the data does not specify a particular catalyst for today&#8217;s rise.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Dr_Lal_Pathlabs_Ltd_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Dr. Lal Pathlabs Ltd. Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,926.4<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,895.1<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Change<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">+Rs 31.3 (+1.65%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,932.7<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Fresh 52-Week High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,950.45<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,910<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Volume<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">5,739<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1.11 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 31,976.9 crore<\/td>\n<\/tr>\n<\/table>\n<p>Dr. Lal Pathlabs Ltd. (LALPATHLAB) traded at Rs 1,926.4. versus the previous close of Rs 1,895.1, a rise of 1.65%. The stock opened at Rs 1,932.7, reached Rs 1,950.45, touched Rs 1,910. Reported volume was 5,739.<\/p>\n<p>Today, Dr. Lal Pathlabs Ltd. opened at Rs 1,932.7 and reached a high of Rs 1,950.45, setting a new 52-week peak. The stock&#8217;s low for the day was Rs 1,910, with a turnover of Rs 1.11 crore. The current volume of 5,739 shares indicates moderate trading activity. The 1.65% increase from the previous close highlights positive investor sentiment. This price action sets the stage for further analysis of the company&#8217;s fundamentals and sector context.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Dr_Lal_Pathlabs_Ltd_LALPATHLAB_Fundamental_Analysis\"><\/span><strong>Dr. Lal Pathlabs Ltd. (LALPATHLAB) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 31,976.9 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">39.39x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">7.98x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">28.21%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">26.35%<\/td>\n<\/tr>\n<\/table>\n<p>Dr. Lal Pathlabs Ltd. was valued at a P\/E ratio of 39.39x, a P\/B ratio of 7.98x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.<\/p>\n<p>Profitability and capital efficiency were represented by ROE of 28.21% and ROCE of 26.35%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same sector<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">39.39x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">20.89x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">73.74x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0x to 3,364.06x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">7.98x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.9x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">28.21%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">10.92%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">26.35%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.29%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 31,976.9 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 139.24 crore<\/td>\n<\/tr>\n<\/table>\n<p>Dr. Lal Pathlabs Ltd. (LALPATHLAB) is classified under sector: Healthcare.<\/p>\n<p>Dr. Lal Pathlabs Ltd. (LALPATHLAB) has a P\/E ratio of 39.39x, which is above the benchmark median of 20.89x, a difference of +88.56%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Dr. Lal Pathlabs Ltd. (LALPATHLAB) has a ROE of 28.21%, which is above the benchmark median of 10.92%, a difference of +158.33%. Dr. Lal Pathlabs Ltd. (LALPATHLAB) has a ROCE of 26.35%, which is above the benchmark median of 13.29%, a difference of +98.27%.<\/p>\n<p>Track stocks reaching yearly peaks through the <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/kpl\/kwality-pharmaceuticals-ltd-share-price-today\"><strong>Kwality Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">KPL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,683.28<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">39.39<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">7.98<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">28.21<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.35<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/beta\/beta-drugs-ltd-share-price-today\"><strong>Beta Drugs Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">BETA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,474.26<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">62.88<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">9.95<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.65<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">22.17<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/dragarwq\/dr-agarwals-eye-hospital-ltd-share-price-today\"><strong>Dr Agarwals Eye Hospital Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DRAGARWQ<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,421.1<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">34.54<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">6.99<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-2.6<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.92<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/saiparent\/sai-parenteral-s-ltd-share-price-today\"><strong>Sai Parenteral&#39;s Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SAIPARENT<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,416.82<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">171.93<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.18<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.9<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">12.97<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/hesterbio\/hester-biosciences-ltd-share-price-today\"><strong>Hester Biosciences Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">HESTERBIO<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,111.45<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">15.25<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.57<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.17<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.12<\/td>\n<\/tr>\n<\/table>\n<p>Dr. Lal Pathlabs Ltd. (LALPATHLAB) has a P\/E ratio of 39.39x compared with the displayed peer median of 39.39x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 28.21% compares with a peer median of 16.17% across the companies shown in the table. ROCE stood at 26.35% versus the displayed peer median of 16.92%, providing a capital-efficiency comparison. Dr. Lal Pathlabs Ltd. (LALPATHLAB) has a market capitalisation of Rs 31,976.9 crore. Among the 5 peers shown, 0 have a larger market capitalisation.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Dr_Lal_Pathlabs_Ltd\"><\/span><strong>Why Investors Are Watching Dr. Lal Pathlabs Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Achieved a fresh 52-week high of Rs 1,950.45.<\/li>\n<li>Strong fundamentals with high ROE and ROCE.<\/li>\n<li>Leading market cap in the healthcare sector.<\/li>\n<li>Valuation metrics above sector medians.<\/li>\n<\/ul>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"About_Dr_Lal_Pathlabs_Ltd\"><\/span><strong>About Dr. Lal Pathlabs Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Dr. Lal Pathlabs Ltd. is a prominent player in the healthcare sector, offering a wide range of diagnostic and related healthcare tests. The company operates a network of laboratories and patient service centers across India, providing services to individual patients, hospitals, and other healthcare providers. Its comprehensive test menu includes routine and specialized tests, catering to a diverse clientele. Dr. Lal Pathlabs Ltd. is known for its quality services and technological advancements, maintaining a strong market presence.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Track_Dr_Lal_Pathlabs_Ltd_Share_Price_on_Univest\"><\/span><strong>Track Dr. Lal Pathlabs Ltd. Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/lalpathlab\/dr-lal-pathlabs-ltd-share-price-today\">Dr. Lal Pathlabs Ltd. (LALPATHLAB) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-high lists and related market analysis.<\/p>\n<p>Investors can track Dr. Lal Pathlabs Ltd. Share Price, technical indicators, fundamental ratios, shareholding pattern, 52-week levels, and market insights on Univest. Stay informed with real-time data and comprehensive analysis.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_current_share_price_of_Dr_Lal_Pathlabs_Ltd\"><\/span><strong>What is the current share price of Dr. Lal Pathlabs Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The current share price of Dr. Lal Pathlabs Ltd. is Rs 1,926.4, marking a 1.65% increase from the previous close of Rs 1,895.1. The stock moved 1.65% during the session.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_52-week_high_of_Dr_Lal_Pathlabs_Ltd\"><\/span><strong>What is the 52-week high of Dr. Lal Pathlabs Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Dr. Lal Pathlabs Ltd. reached a 52-week high of Rs 1,950.45 today, reflecting strong market performance. The stock moved 1.65% during the session. The intraday range extended from Rs 1,910 to Rs 1,950.45.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Dr_Lal_Pathlabs_Ltds_PE_ratio_compare_to_the_sector\"><\/span><strong>How does Dr. Lal Pathlabs Ltd.&#39;s P\/E ratio compare to the sector?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Dr. Lal Pathlabs Ltd.&#39;s P\/E ratio of 39.39 is higher than the healthcare sector median of 20.89, indicating a premium valuation. The company trades at a P\/E ratio of 39.39x.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_capitalisation_of_Dr_Lal_Pathlabs_Ltd\"><\/span><strong>What is the market capitalisation of Dr. Lal Pathlabs Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Dr. Lal Pathlabs Ltd. has a market capitalisation of Rs 31,976.9 crore, positioning it as a major player in the healthcare sector. The company operates in the Healthcare sector. Its P\/E ratio is 39.39x.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Dr_Lal_Pathlabs_Ltds_ROE_compare_to_its_peers\"><\/span><strong>How does Dr. Lal Pathlabs Ltd.&#39;s ROE compare to its peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Dr. Lal Pathlabs Ltd.&#39;s ROE of 28.21% is higher than many of its peers, showcasing strong profitability and efficient capital use. ROE stands at 28.21%. ROCE stands at 26.35%. The relevant peer median ROE is 10.92%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_PB_ratio_of_Dr_Lal_Pathlabs_Ltd\"><\/span><strong>What is the P\/B ratio of Dr. Lal Pathlabs Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The P\/B ratio of Dr. Lal Pathlabs Ltd. is 7.98, which is above the sector median of 1.9, indicating a higher valuation. The company trades at a P\/E ratio of 39.39x.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Who_are_the_peers_of_Dr_Lal_Pathlabs_Ltd\"><\/span><strong>Who are the peers of Dr. Lal Pathlabs Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Peers of Dr. Lal Pathlabs Ltd. include Kwality Pharmaceuticals Ltd., Beta Drugs Ltd., and Dr Agarwals Eye Hospital Ltd., among others. Comparable listed companies include Kwality Pharmaceuticals Ltd., Beta Drugs Ltd., Dr Agarwals Eye Hospital Ltd.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Dr_Lal_Pathlabs_Ltds_ROCE_compare_to_the_sector\"><\/span><strong>How does Dr. Lal Pathlabs Ltd.&#39;s ROCE compare to the sector?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Dr. Lal Pathlabs Ltd.&#39;s ROCE of 26.35% is significantly higher than the sector median of 13.29%, indicating efficient capital use. ROE stands at 28.21%. ROCE stands at 26.35%. The relevant peer median ROE is 10.92%.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dr. Lal Pathlabs Ltd. Share Price hits a new 52-week high at Rs 1,926.4. marking a 1.65% rise today. Market cap stands at Rs 31,976.9 crore.<\/p>\n","protected":false},"author":29,"featured_media":182483,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-182484","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["182483"],"rank_math_title":["Dr. Lal Pathlabs Ltd. Share Price Surges to 52-Week High"],"rank_math_description":["Dr. Lal Pathlabs Ltd. Share Price hits a 52-week high at Rs 1,950.45. Explore price action, fundamentals, and sector analysis in this comprehensive report."],"rank_math_focus_keyword":["Dr. Lal Pathlabs Ltd. Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/08\/Dr_Lal_Pathlabs_Ltd_LALPATHLAB_Share_Price_Hits_52_Week_High_bullish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/182484","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=182484"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/182484\/revisions"}],"predecessor-version":[{"id":182485,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/182484\/revisions\/182485"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/182483"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=182484"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=182484"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=182484"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}